| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Mai―14 |
Clostridioides difficile infection in patients with and without COVID-19 during the pandemic: a retrospective cohort study from a tertiary referral hospital. |
Alexandra Tsankof, Adonis A. Protopapas, Paraskevi Mantzana, Efthymia Protonotariou, Lemonia Skoura, Andreas N. Protopapas, et al. (+2) Christos Savopoulos, Konstantinos Mimidis |
| 2 |
[GO] |
2024―Feb―28 |
Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: A retrospective cohort study in a tertiary care hospital from 2019 to 2022 |
Alfredo Maldonado-Barrueco, Francisco Moreno-Ramos, Beatriz Díaz-Pollán, Belén Loeches-Yagüe, Alicia Rico-Nieto, Julio García-Rodríguez, Guillermo Ruiz-Carrascoso |
| 3 |
[GO] |
2023―Jan―23 |
Walk before you run: Feasibility challenges and lessons learned from the PROCLAIM study, a multicenter randomized controlled trial of misoprostol for prevention of recurrent C. difficile during COVID-19 |
Robert R. Lavieri, Erik R. Dubberke, Sarah K. McGill, Luther Bartelt, Stephanie A. Smith, Balint K. Pandur, et al. (+10) Sharon E. Phillips, Krista Vermillion, Jana Shirey-Rice, Jill Pulley, Yaomin Xu, Christopher J. Lindsell, Nicole Zaleski, Rebecca Jerome, Ryan S. Doster, David M. Aronoff |
| 4 |
[GO] |
2023―Jan―07 |
Impact of the COVID-19 pandemic on the incidence of healthcare facility-onset Clostridioides difficile infection in hospitalized patients with sepsis: Interrupted time series analysis using Japanese Diagnosis Procedure Combination data |
Koji Endo, Kayoko Mizuno, Masato Takeuchi, Koji Kawakami |
| 5 |
[GO] |
2022―Apr―30 |
Impact of COVID19 pandemic on the incidence of health-care associated Clostridioides difficile infection |
Nicolás Merchante, Pablo Chico, Esther Márquez-Saavedra, Gerónima Riera, Rocío Herrero, Pilar González-de-la-Aleja, et al. (+6) Ana I. Aller, Juan Carlos Rodríguez, Miguel Rodríguez-Fernández, José Manuel Ramos, Marta Trigo-Rodríguez, Esperanza Merino |
| 6 |
[GO] |
2022―Jan―19 |
Clostridioides difficile infection (CDI) during the COVID-19 pandemic |
Patrizia Spigaglia |
| 7 |
[GO] |
2021―Nov―26 |
The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis |
Guido Granata, Nicola Petrosillo, Samir Al Moghazi, Emanuela Caraffa, Vincenzo Puro, Glenn Tillotson, Maria Adriana Cataldo |
| 8 |
[GO] |
2021―Nov―18 |
Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre |
Sanjana Voona, Heather Abdic, Ros Montgomery, Annette Clarkson, Hannah Twitchell, Tim Hills, et al. (+3) Steve Briggs, Colin Crooks, Tanya M. Monaghan |
| 9 |
[GO] |
2021―Jul―24 |
Septic hip abscess due to Fusobacterium nucleatum and Actinomyces turicensis in an immunocompetent SARS-CoV-2 positive patient |
A. Nia, A. Ungersboeck, M. Uffmann, D. Leaper, O. Assadian |
| 10 |
[GO] |
2021―Mai―26 |
Botulism during SARS-CoV-2 pandemic: the importance of differential diagnoses |
Antonio Gatto, Silvia Pulitano, Giorgio Conti, Paolo Maurizio Soave, Lorenzo Di Sarno, Antonio Chiaretti |
| 11 |
[GO] |
2021―Mai―23 |
Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic? |
Armani Minasian Hawes, Angel Desai, Payal K. Patel |
| 12 |
[GO] |
2020―Jun―25 |
COVID-19 and Clostridioides difficile infection (CDI): Possible implications for elderly patients |
Patrizia Spigaglia |
|
